Back to Home
Free CE/CMEAudio

Breaking Down the Latest Clinical Data for First-line Maintenance and R/R SCLC

Release Date

August 20, 2025

Expiration Date

August 21, 2026

Credits

0.25 CME

Specialties

General Oncology, Lung Cancer+1 more

Release Date: August 20, 2025

Expiration Date: August 20, 2026

Activity Overview

The management of extensive-stage small cell lung cancer (ES-SCLC) is poised to change substantially with recent practice-changing trial data. Navigating optimal management for patients along the treatment continuum is critical for extending the lives of patients with this form of cancer.

This podcast features a discussion about the current standard of care in terms of molecular testing and management of lung cancer. Led by Rohit Gosain, MD; and Rahul Gosain, MD; this session features a faculty expert in evaluating and treating cancers.

Target Audience

This educational activity is intended for medical oncologists, nurse practitioners, physician assistants, and oncology nurses who manage patients with SCLC.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Analyze recent clinical trial data on new maintenance strategies and treatment options for relapsed/refractory ES-SCLC
  • Recognize the unmet clinical needs in SCLC and potential opportunities to improve patient outcomes
Breaking Down the Latest Clinical Data for First-line Maintenance and R/R SCLC

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Related Content

Course

Breaking Down the Latest Clinical Data for First-line Maintenance and R/R SCLC

Create Account